INFORMATION TECHNOLOGY
DRIVEN BY DATA A ROADMAP TO BIOPHARMA’S DIGITAL FUTURE Biopharma’s efforts to digitally transform operations are proving more important than ever to drive improvements in process efficiency and deliver essential treatments to patients. However, the industry’s attempts are returning mixed results and the digital transformations of many enterprises remain in early-phase development. As with any business initiative, a lack of clear goals and strategies keeps some biopharma programs from being successful. As a result, these shortfalls may be further preventing many companies from moving toward the more data-driven future the industry needs to deliver reliable access to better performing, more affordable medicines. It is clear biopharma needs a shared vision and a strategic roadmap to achieve digital transformation. Samsung Biologics’ technology strategist James Choi proposes an instrumental strategy that could drive the digital transformation of biopharma organisations and prepare themselves and the industry for the road ahead. James Choi, Executive Vice President and Chief Information & Marketing Officer and head of Global Public Relations and Process Improvement, Samsung Biologics
54
P H A RM A F O C U S A S I A
ISSUE 44 46 - 2021 2022
D
espite great effort and expense implementing data-driven business models and processes, the biopharma industry’s attempts to digitally transform operations are returning mixed results. Those in the industry understand the competitive and pertinent imperatives, especially post COVID-19, but recent polling indicates that for many enterprises, their digital transformations remain in early-phase development. As with any business initiative, lack of standards, vision, and strategy are hindering digitalisation programs from success. This is preventing biopharma from moving toward the more data-driven future which the industry needs to offer reliable accessibility to better performing and more affordable medicines. It is clear that biopharma needs a shared vision and a clear strategic roadmap to achieve digital transformation. Samsung Biologics’ Executive Vice President and Chief Information & Marketing Officer
